89 related articles for article (PubMed ID: 15618545)
1. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells.
Djordjevic T; BelAiba RS; Bonello S; Pfeilschifter J; Hess J; Görlach A
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):519-25. PubMed ID: 15618545
[TBL] [Abstract][Full Text] [Related]
2. KRIT1: A Traffic Warden at the Busy Crossroads Between Redox Signaling and the Pathogenesis of Cerebral Cavernous Malformation Disease.
Perrelli A; Ferraris C; Berni E; Glading AJ; Retta SF
Antioxid Redox Signal; 2023 Mar; 38(7-9):496-528. PubMed ID: 36047808
[No Abstract] [Full Text] [Related]
3. Targeting the Urotensin II/UT G Protein-Coupled Receptor to Counteract Angiogenesis and Mesenchymal Hypoxia/Necrosis in Glioblastoma.
Le Joncour V; Guichet PO; Dembélé KP; Mutel A; Campisi D; Perzo N; Desrues L; Modzelewski R; Couraud PO; Honnorat J; Ferracci FX; Marguet F; Laquerrière A; Vera P; Bohn P; Langlois O; Morin F; Gandolfo P; Castel H
Front Cell Dev Biol; 2021; 9():652544. PubMed ID: 33937253
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidase 4 and its role in the cardiovascular system.
Gray SP; Shah AM; Smyrnias I
Vasc Biol; 2019; 1(1):H59-H66. PubMed ID: 32923955
[TBL] [Abstract][Full Text] [Related]
5. Urotensin II promotes secretion of LTB
Lu D; Peng F; Li J; Zhao J; Ye X; Li B; Ding W
Arch Med Sci; 2019 Jul; 15(4):1065-1072. PubMed ID: 31360201
[TBL] [Abstract][Full Text] [Related]
6. EPAS 1, congenital heart disease, and high altitude: disclosures by genetics, bioinformatics, and experimental embryology.
Sergi C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015364
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension.
Huetsch JC; Suresh K; Shimoda LA
Antioxidants (Basel); 2019 Mar; 8(3):. PubMed ID: 30841544
[TBL] [Abstract][Full Text] [Related]
8. Protective role of epigallocatechin-3-gallate in NADPH oxidase-MMP2-Spm-Cer-S1P signalling axis mediated ET-1 induced pulmonary artery smooth muscle cell proliferation.
Sarkar J; Chakraborti T; Chowdhury A; Bhuyan R; Chakraborti S
J Cell Commun Signal; 2019 Dec; 13(4):473-489. PubMed ID: 30661173
[TBL] [Abstract][Full Text] [Related]
9. The Role of Nicotinamide Adenine Dinucleotide Phosphate Oxidases in Lung Architecture Remodeling.
Harijith A; Natarajan V; Fu P
Antioxidants (Basel); 2017 Dec; 6(4):. PubMed ID: 29257052
[TBL] [Abstract][Full Text] [Related]
10. The G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.
Castel H; Desrues L; Joubert JE; Tonon MC; Prézeau L; Chabbert M; Morin F; Gandolfo P
Front Endocrinol (Lausanne); 2017; 8():76. PubMed ID: 28487672
[TBL] [Abstract][Full Text] [Related]
11. A Novel Urotensin II Receptor Antagonist, KR-36996 Inhibits Smooth Muscle Proliferation through ERK/ROS Pathway.
Kim TH; Lee DG; Kim YA; Lee BH; Yi KY; Jung YS
Biomol Ther (Seoul); 2017 May; 25(3):308-314. PubMed ID: 28173642
[TBL] [Abstract][Full Text] [Related]
12. Blockade of Urotensin II Receptor Prevents Vascular Dysfunction.
Kim YA; Lee DG; Yi KY; Lee BH; Jung YS
Biomol Ther (Seoul); 2016 Sep; 24(5):523-8. PubMed ID: 27582556
[TBL] [Abstract][Full Text] [Related]
13. Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.
Kigawa Y; Miyazaki T; Lei XF; Kim-Kaneyama JR; Miyazaki A
J Atheroscler Thromb; 2017 Jan; 24(1):1-13. PubMed ID: 27476665
[TBL] [Abstract][Full Text] [Related]
14. Urotensin II-induced insulin resistance is mediated by NADPH oxidase-derived reactive oxygen species in HepG2 cells.
Li YY; Shi ZM; Yu XY; Feng P; Wang XJ
World J Gastroenterol; 2016 Jul; 22(25):5769-79. PubMed ID: 27433090
[TBL] [Abstract][Full Text] [Related]
15. TLR4 regulates pulmonary vascular homeostasis and remodeling via redox signaling.
Ma L; Ambalavanan N; Liu H; Sun Y; Jhala N; Bradley WE; Dell'Italia LJ; Michalek S; Wu H; Steele C; Benza RL; Chen Y
Front Biosci (Landmark Ed); 2016 Jan; 21(2):397-409. PubMed ID: 26709781
[TBL] [Abstract][Full Text] [Related]
16. Urotensin-II-Mediated Reactive Oxygen Species Generation via NADPH Oxidase Pathway Contributes to Hepatic Oval Cell Proliferation.
Yu X; Wang P; Shi Z; Dong K; Feng P; Wang H; Wang X
PLoS One; 2015; 10(12):e0144433. PubMed ID: 26658815
[TBL] [Abstract][Full Text] [Related]
17. Urotensin II Protects Cardiomyocytes from Apoptosis Induced by Oxidative Stress through the CSE/H2S Pathway.
Gong H; Chen Z; Zhang X; Li Y; Zhang J; Chen Y; Ding Y; Zhang G; Yang C; Zhu Y; Zou Y
Int J Mol Sci; 2015 Jun; 16(6):12482-98. PubMed ID: 26047336
[TBL] [Abstract][Full Text] [Related]
18. NOX4 mediates BMP4-induced upregulation of TRPC1 and 6 protein expressions in distal pulmonary arterial smooth muscle cells.
Jiang Q; Fu X; Tian L; Chen Y; Yang K; Chen X; Zhang J; Lu W; Wang J
PLoS One; 2014; 9(9):e107135. PubMed ID: 25203114
[TBL] [Abstract][Full Text] [Related]
19. Essential hypertension and oxidative stress: New insights.
González J; Valls N; Brito R; Rodrigo R
World J Cardiol; 2014 Jun; 6(6):353-66. PubMed ID: 24976907
[TBL] [Abstract][Full Text] [Related]
20. Lycopene Inhibits Urotensin-II-Induced Cardiomyocyte Hypertrophy in Neonatal Rat Cardiomyocytes.
Chao HH; Sung LC; Chen CH; Liu JC; Chen JJ; Cheng TH
Evid Based Complement Alternat Med; 2014; 2014():724670. PubMed ID: 24971153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
